Canary’s INJC staked Injective ETF debuted on Nasdaq on Nov. 5 and held $16.12 million in assets by Friday, with 600,000 shares and staking built in.

Canary’s INJC staked Injective ETF debuted on Nasdaq on Nov. 5 and held $16.12 million in assets by Friday, with 600,000 shares and staking built in.